. Unaids, Report on the global AIDS epidemic. Geneva, 2006.

C. Seyler, X. Anglaret, N. Dakoury-dogbo, E. Messou, S. Toure et al., Medium-term survival, morbidity and immunovirological evolution in HIV-infected preventable infections in Malawian adults living with HIV CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in Uganda, J Acquir Immune Defic Syndr J Infect, vol.3945, issue.162, pp.626-3199, 2002.

N. French, J. Nakiyingi, E. Lugada, C. Watera, J. Whitworth et al., Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults, AIDS, vol.15, issue.7, pp.899-906, 2001.
DOI : 10.1097/00002030-200105040-00010

J. Whitworth, D. Morgan, M. Quigley, A. Smith, B. Mayanja et al., Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study, The Lancet, vol.356, issue.9235, pp.1051-1057, 2000.
DOI : 10.1016/S0140-6736(00)02727-6

M. Badri, D. Wilson, and R. Wood, Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study, The Lancet, vol.359, issue.9323, pp.2059-64, 2002.
DOI : 10.1016/S0140-6736(02)08904-3

F. Palella, J. Delaney, K. Moorman, A. Loveless, M. Fuhrer et al., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy, N Engl J Med Arch Intern Med, vol.338165, issue.134, pp.853-60416, 1998.

K. Anastos, Y. Barron, M. Cohen, R. Greenblatt, H. Minkoff et al., The Prognostic Importance of Changes in CD4^+Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy, Annals of Internal Medicine, vol.140, issue.4, pp.256-64, 2004.
DOI : 10.7326/0003-4819-140-4-200402170-00007

R. Moh, C. Danel, S. Sorho, D. Sauvageot, A. Anzian et al., Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire, Antivir Ther, vol.10, issue.5, pp.615-639, 2005.

C. Gilks, P. Godfrey-faussett, B. Batchelor, J. Ojoo, S. Ojoo et al., Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya, AIDS, vol.11, issue.7, pp.911-919, 1997.
DOI : 10.1097/00002030-199707000-00011

C. Gilks, S. Ojoo, J. Ojoo, R. Brindle, J. Paul et al., Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya, The Lancet, vol.347, issue.9003, pp.718-741, 1996.
DOI : 10.1016/S0140-6736(96)90076-8

M. Gordon, H. Banda, M. Gondwe, S. Gordon, M. Boeree et al., Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence, AIDS, vol.16, issue.12, pp.1633-1674, 2002.
DOI : 10.1097/00002030-200208160-00009

P. Sonnenberg, J. Murray, J. Glynn, S. Shearer, B. Kambashi et al., HIV- 1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIVinfected men in South Africa: a novel randomized incremental recruitment study, Lancet Jama, vol.358293, issue.929422, pp.1687-932719, 2001.

G. Antonucci, E. Girardi, M. Raviglione, and G. Ippolito, Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA), JAMA: The Journal of the American Medical Association, vol.274, issue.2, pp.143-151, 1995.
DOI : 10.1001/jama.274.2.143

C. Seyler, S. Toure, E. Messou, D. Bonard, D. Gabillard et al., Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes?, Am J Respir Crit Care Med Int J Tuberc Lung Dis, vol.1727, issue.17, pp.123-130, 2003.

M. Badri, L. Bekker, C. Orrell, J. Pitt, F. Cilliers et al., Initiating highly active antiretroviral therapy in sub-Saharan Africa, AIDS, vol.18, issue.8, pp.1159-68, 2004.
DOI : 10.1097/00002030-200405210-00009

A. Cassone, E. Tacconelli, D. Bernardis, F. Tumbarello, M. Torosantucci et al., Virulence and Oral Candidiasis in Human Immunodeficiency Virus???Infected Subjects, The Journal of Infectious Diseases, vol.185, issue.2, pp.188-95, 2002.
DOI : 10.1086/338445

T. Skinner-adams, J. Mccarthy, D. Gardiner, P. Hilton, and K. Andrews, Antiretrovirals as Antimalarial Agents, The Journal of Infectious Diseases, vol.190, issue.11, pp.1998-2000, 2004.
DOI : 10.1086/425584

D. Konopnicki, A. Mocroft, S. De-wit, F. Antunes, B. Ledergerber et al., Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort, AIDS, vol.19, issue.6, pp.593-601, 2005.
DOI : 10.1097/01.aids.0000163936.99401.fe

F. Rouet, M. Chaix, A. Inwoley, P. Msellati, I. Viho et al., HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, C??te d'Ivoire: The ANRS 1236 study, Journal of Medical Virology, vol.40, issue.2 Suppl, pp.34-40, 2004.
DOI : 10.1002/jmv.20143

M. French, P. Price, and S. Stone, Immune restoration disease after antiretroviral therapy, AIDS, vol.18, issue.12, pp.1615-1642, 2004.
DOI : 10.1097/01.aids.0000131375.21070.06

N. Kumarasamy, S. Chaguturu, K. Mayer, S. Solomon, H. Yepthomi et al., Incidence of Immune Reconstitution Syndrome in HIV/Tuberculosis-Coinfected Patients After Initiation of Generic Antiretroviral Therapy in India Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals, J Acquir Immune Defic Syndr Aids Lancet Infect Dis, vol.37175, issue.39146, pp.1574-15762129, 2003.